Anti-thrombotic therapy in non-ST elevation acute coronary syndrome KAA Fox
Platelet activation and thrombin generation are implicated in the pathogenesis of acute coronary syndrome, in the development of major thrombotic complications of the condition, and in the interventional treatments to treat obstructive coronary lesions (principally, percutaneous coronary interventio...
Main Author: | Keith A.A. Fox |
---|---|
Format: | Article |
Language: | English |
Published: |
South African Heart Association
2017-04-01
|
Series: | SA Heart Journal |
Subjects: | |
Online Access: | https://www.journals.ac.za/index.php/SAHJ/article/view/2104 |
Similar Items
-
Anti-thrombotic therapy strategies with long-term anticoagulation after percutaneous coronary intervention – a systematic review and meta-analysis
by: Waqas Javed Siddiqui, et al.
Published: (2019-05-01) -
Novel agents for anti-platelet therapy
by: Ji Xuebin, et al.
Published: (2011-11-01) -
Anti-platelet agents in pediatric cardiac practice
by: Sweta Mohanty, et al.
Published: (2013-01-01) -
Using PAR4 Inhibition as an Anti-Thrombotic Approach: Why, How, and When?
by: Simeng Li, et al.
Published: (2019-11-01) -
Appropriate use of anti-thrombotic therapy in patients with atrial fibrillation at single-center experience, Northwest Ethiopia
by: Ermiyas Endewunet, et al.
Published: (2020-08-01)